245 related articles for article (PubMed ID: 27356882)
21. Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes.
Beauchamp P; Moritz W; Kelm JM; Ullrich ND; Agarkova I; Anson BD; Suter TM; Zuppinger C
Tissue Eng Part C Methods; 2015 Aug; 21(8):852-61. PubMed ID: 25654582
[TBL] [Abstract][Full Text] [Related]
22. Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences.
Abi-Gerges N; Miller PE; Ghetti A
Curr Pharm Biotechnol; 2020; 21(9):787-806. PubMed ID: 31820682
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive in vitro cardiac safety assessment using human stem cell technology: Overview of CSAHi HEART initiative.
Takasuna K; Asakura K; Araki S; Ando H; Kazusa K; Kitaguchi T; Kunimatsu T; Suzuki S; Miyamoto N
J Pharmacol Toxicol Methods; 2017; 83():42-54. PubMed ID: 27646297
[TBL] [Abstract][Full Text] [Related]
24. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
Ting S; Chen A; Reuveny S; Oh S
Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
[TBL] [Abstract][Full Text] [Related]
25. Engineered heart slices for electrophysiological and contractile studies.
Blazeski A; Kostecki GM; Tung L
Biomaterials; 2015 Jul; 55():119-28. PubMed ID: 25934457
[TBL] [Abstract][Full Text] [Related]
26. Slicing and Culturing Pig Hearts under Physiological Conditions.
Ou Q; Abouleisa RRE; Tang XL; Juhardeen HR; Meki MH; Miller JM; Giridharan G; El-Baz A; Bolli R; Mohamed TMA
J Vis Exp; 2020 Mar; (157):. PubMed ID: 32250357
[TBL] [Abstract][Full Text] [Related]
27. Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.
Zeng H; Roman MI; Lis E; Lagrutta A; Sannajust F
J Pharmacol Toxicol Methods; 2016; 81():217-22. PubMed ID: 27222351
[TBL] [Abstract][Full Text] [Related]
28. CGRP-alpha responsiveness of adult rat ventricular cardiomyocytes from normotensive and spontaneously hypertensive rats.
Schlier A; Schreckenberg R; Abdallah Y; Krasteva G; Piper HM; Pfeil U; Kummer W; Schlüter KD
Eur J Cell Biol; 2009 Apr; 88(4):227-41. PubMed ID: 19128857
[TBL] [Abstract][Full Text] [Related]
29. Human cardiac progenitor cell grafts as unrestricted source of supernumerary cardiac cells in healthy murine hearts.
Forte G; Pietronave S; Nardone G; Zamperone A; Magnani E; Pagliari S; Pagliari F; Giacinti C; Nicoletti C; Musaró A; Rinaldi M; Ribezzo M; Comoglio C; Traversa E; Okano T; Minieri M; Prat M; Di Nardo P
Stem Cells; 2011 Dec; 29(12):2051-61. PubMed ID: 22009661
[TBL] [Abstract][Full Text] [Related]
30. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
[TBL] [Abstract][Full Text] [Related]
31. Human placenta hydrogel reduces scarring in a rat model of cardiac ischemia and enhances cardiomyocyte and stem cell cultures.
Francis MP; Breathwaite E; Bulysheva AA; Varghese F; Rodriguez RU; Dutta S; Semenov I; Ogle R; Huber A; Tichy AM; Chen S; Zemlin C
Acta Biomater; 2017 Apr; 52():92-104. PubMed ID: 27965171
[TBL] [Abstract][Full Text] [Related]
32. A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing.
Maddah M; Heidmann JD; Mandegar MA; Walker CD; Bolouki S; Conklin BR; Loewke KE
Stem Cell Reports; 2015 Apr; 4(4):621-31. PubMed ID: 25801505
[TBL] [Abstract][Full Text] [Related]
33. Modeling trastuzumab-related cardiotoxicity in vitro using human stem cell-derived cardiomyocytes.
Kurokawa YK; Shang MR; Yin RT; George SC
Toxicol Lett; 2018 Mar; 285():74-80. PubMed ID: 29305325
[TBL] [Abstract][Full Text] [Related]
34. Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing.
Bielawski KS; Leonard A; Bhandari S; Murry CE; Sniadecki NJ
Tissue Eng Part C Methods; 2016 Oct; 22(10):932-940. PubMed ID: 27600722
[TBL] [Abstract][Full Text] [Related]
35. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
[TBL] [Abstract][Full Text] [Related]
36. Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts.
Garreta E; de Oñate L; Fernández-Santos ME; Oria R; Tarantino C; Climent AM; Marco A; Samitier M; Martínez E; Valls-Margarit M; Matesanz R; Taylor DA; Fernández-Avilés F; Izpisua Belmonte JC; Montserrat N
Biomaterials; 2016 Aug; 98():64-78. PubMed ID: 27179434
[TBL] [Abstract][Full Text] [Related]
37. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
Clements M; Millar V; Williams AS; Kalinka S
Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
[TBL] [Abstract][Full Text] [Related]
38. A Protocol for Transverse Cardiac Slicing and Optical Mapping in Murine Heart.
He S; Wen Q; O'Shea C; Mu-U-Min R; Kou K; Grassam-Rowe A; Liu Y; Fan Z; Tan X; Ou X; Camelliti P; Pavlovic D; Lei M
Front Physiol; 2019; 10():755. PubMed ID: 31293436
[TBL] [Abstract][Full Text] [Related]
39. Murine transgenic iPS cell line for monitoring and selection of cardiomyocytes.
Fatima A; Xu G; Nguemo F; Kuzmenkin A; Burkert K; Hescheler J; Šarić T
Stem Cell Res; 2016 Sep; 17(2):266-272. PubMed ID: 27879210
[TBL] [Abstract][Full Text] [Related]
40. An in vitro beating heart model for long-term assessment of experimental therapeutics.
Habeler W; Pouillot S; Plancheron A; Pucéat M; Peschanski M; Monville C
Cardiovasc Res; 2009 Feb; 81(2):253-9. PubMed ID: 18980954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
